Raqualia Pharma Inc.

Japon


 
Quantité totale PI 120
Quantité totale incluant filiales 128 (+ 8 pour les filiales)
Rang # Quantité totale PI 10 820
Note d'activité PI 2,5/5.0    38
Rang # Activité PI 19 797
Activité incl filiales 2,2/5.0    39
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

33 5
27 3
47 5
0
 
Dernier brevet 2024 - Crystalline forms
Premier brevet 1996 - Growth-hormone secretagogues
Dernière marque 2020 - RaQualia Innovations
Première marque 2008 - RAQUALIA

Filiales

1 subsidiaries with IP (8 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 Invention Crystalline forms. The present invention relates to novel crystalline forms of (R)—N—((S)-1-(4-(...
Invention Crystalline forms. The present invention relates to novel crystalline forms of (R)-N-((S)-1-(4-(3...
Invention Tetrahydroquinoline derivatives as p2x7 receptor antagonists. The present invention relates to t...
2021 Invention 3-hydroxyoxindole derivatives as crhr2 antagonist. The present invention relates to 3-hydroxyoxi...
Invention 3-hydroxyoxindole derivatives as crhr2 antagonist. The present invention relates to 3-hydroxyoxin...
Invention Method for preventing or treating heart failure by administering a medicament containing an antag...
Invention Trpv4 inhibitor as a therapeutic agent for ocular diseases. The present invention relates to a u...
Invention Trpv4 inhibitor as therapeutic agent for ocular disease. The present invention relates to the use...
Invention Trpv4 inhibitor as therapeutic drug for eye disease. The present invention relates to the use of ...
Invention Method for selecting cancer patients for whom combination therapy with retinoid and cancer therap...
Invention Method for selecting cancer patient for which combination therapy of retinoid and cancer treatmen...
Invention Pyrimidin-4(3h)-one derivatives as trpv4 antagonists. This invention relates to pyrimidin-4(3H)-...
Invention Pyrimidin-4(3h)-one derivatives as trpv4 antagonists. This invention relates to pyrimidin-4(3H)-o...
Invention Ghrelin receptor agonist for treatment of cachexia. The present invention relates to use of a co...
Invention Spiroheterocyclic derivatives as crhr2 antagonist. The present invention relates to spiroheterocy...
2020 Invention Tetrahydroquinoline derivatives as p2x7 receptor antagonists. The present invention relates to te...
P/S Pharmaceutical preparations; veterinary preparations; sanitary preparations for medical purposes...
P/S Pharmaceutical preparations for the treatment of pain, GI (gastrointestinal disease), cancer, CNS...
2019 Invention Heterocyclic derivatives as nav1.7 and nav1.8 blockers. The present invention relates to heterocy...
P/S Pharmaceutical preparations for the treatment of pain, namely, chronic pain, inflammatory pain, m...
P/S Pharmaceutical preparations; preparations for destroying vermin; fungicides; herbicides. Testing...
P/S Pharmaceutical preparations for the treatment of pain, gastrointestinal disease, cancer, and cent...
Invention Fused cyclic urea derivatives as crhr2 antagonist. The present invention relates to fused cyclic ...
2018 Invention Biaryloxy derivatives as ttx-s blockers. The present invention relates to biaryloxy derivatives w...
Invention Azaspiro derivatives as trpm8 antagonists. The present invention relates to azaspiro derivatives...
Invention Amide derivatives as nav1.7 and nav1.8 blockers. The present invention relates to amide derivativ...
Invention Medicament for preventing or treating heart failure. A novel medicament for preventing or treatin...
2016 Invention Imidazolinone derivatives as trpm8 antagonists. The present invention relates to imidazolinone d...
Invention Imidazolinone derivatives as trpm8 antagonists. The present invention relates to imidazolinone de...
Invention Uses of benzimidazole derivative for nocturnal acid breakthrough. The present application relates...
2015 Invention Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists. The present invention relate...
Invention Serine derivatives as ghrelin receptor agonists. The present invention relates to novel compounds...
Invention Benzisoxazole derivative salt. Salts of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]...
Invention Benzisoxazole derivative salt. The present invention relates to novel salts of 4- {[4-( {[4-(2,2,...
Invention Benzisoxazole derivative salt. The present invention relates to novel salts of 4-{[4-({[4-(2,2,2-...
Invention 5-ht4 receptor agonist for gastroparesis. This invention relates to 4-{[4-({([4-(2,2,2-trifluoroe...
Invention Azaspiro derivatives as trpm8 antagonists. The present invention relates to azaspiro derivatives ...
2014 Invention Polymorph forms. The present invention relates to novel crystal forms of 2-amino-N-[2-(3a-(R)-ben...
2013 P/S Pharmaceutical preparations for the treatment of chronic pain, inflammatory pain, pain, namely mi...
2012 P/S Pharmaceutical preparations for the treatment of pain, GI, cancer, and CNS disorder, infectious, ...
P/S Pharmaceutical, veterinary and sanitary preparations. Testing, research or development of pharmac...
2010 P/S Pharmaceutical preparations. Testing, research or development of pharmaceutical preparations, ch...
2008 P/S Pharmaceutical preparation for the treatment of pain, GI, cancer, and CNS disorder, infectious, m...